Inti Labs was formed by embryologist Dr. Barry Behr and RNA researcher Dr. Eric Pok Yang’s mutual drive to develop non-invasive IVF testing solutions. Their vision: refining the IVF process to reliably deliver a healthy baby using a single egg, embryo, and implantation.
ora™ is the first non-invasive endometrial receptivity test, using microRNA biomarkers in the blood to identify the patient’s WOI. When integrated early into the patient’s treatment plan, ora™ eliminates the need for a mock cycle.